Health TrialsbyHealthPanel

Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors

ConditionsCancerSurvivorship
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this study is to evaluate different combinations of cancer education sessions, counseling sessions, and peer support meetings developed for Chinese cancer patients and survivors. The researchers will look at whether the combinations are practical and effective, and how they impact participants' quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed with cancer (any type/stage) (per EMR for MSK patients or self-report for external participants) within the last 5 years

Age ≥ 18 years (per EMR for MSK patients or self-report for external participants)

Of Chinese descent

Speaks Mandarin "well" or "very well"

Disqualifiers

Per PI determination, requires a higher level of care for current passive or active suicidal ideation than current protocol is able to provide. If a participant receives a score of > 0 on item 9 of the PHQ-9,5 they will be referred to study PI for further evaluation using the Columbia-Suicide Severity Rating Scale. They will be excluded from participation in this study if there is presence of suicidal risk, determined by affirmative response(s) on the Columbia-Suicide Severity Rating Scale (C-SSRS)

Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?"

Cognitive impairment (Montreal Cognitive Assessment 5 Minute - telephone version with a score < 12)

Per consenting professional determination, unable to understand the informed consent procedure

Trial design

Design model

Factorial

Treatments tested in this trial

  • Cancer Education

    Other intervention

    Cancer Education on side effects and their management, treatment options, advance care planning, and survivorship. Each session will last about 30-60 minutes and will be completed over the phone or by video call.

  • Meaning-Centered Counseling

    Other intervention

    Meaning-centered counseling aims to activate culturally relevant meaning-focused coping strategies in Chinese-speaking patients and survivors (CCS). Each session will last about 45-60 minutes and will be completed over the phone or by video call.

  • Peer Support

    Other intervention

    Peer support aims to increase social support for CCS to decrease cancer stigma, which has been associated with greater psychological distress, especially among less acculturated Chinese immigrant CCS. The meetings will include up to 6-8 Mandarin-speaking patients and survivors and will last about 90 minutes.

  • Enhanced Standard Care

    Other intervention

    enhanced standard care ( written cancer information materials in Chinese and referral to counseling)

Treatment groups

64 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Group A: 1 - Cancer Education + Meaning-Centered Counseling + Peer Support + Enhanced Standard CareExperimental treatment 4 interventions
Group B: 2 - Cancer Education + Meaning-Centered Counseling + Enhanced Standard CareExperimental treatment 3 interventions
Group C: 3 - Cancer Education + Peer Support + Enhanced Standard CareExperimental treatment 3 interventions
Group D: 4 - Cancer Education + Enhanced Standard CareExperimental treatment 2 interventions
Group E: 5 - Meaning-Centered Counseling + Peer Support + Enhanced Standard CareExperimental treatment 3 interventions
Group F: 6 - Meaning-Centered Counseling- + Enhanced Standard CareExperimental treatment 2 interventions
Group G: 7 - Peer Support + Enhanced Standard CareExperimental treatment 2 interventions
Group H: 8 - Enhanced Standard CareActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Proportion of eligible participants who enroll in the trial.

Time frame
2 years
2

Proportion of participants who complete treatment

Pproportion of assessments that are completed, with completion defined as submitting the 24-week assessment with a minimum of the FACT-G completed.

Time frame
24 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Memorial Sloan Kettering Cancer Center

Lead sponsor

American Cancer Society, Inc.

Collaborator

Brooklyn College Cancer Center

Collaborator

Herald Cancer Association

Collaborator

Source ClinicalTrials.gov
Apply now